DESCRIPTION:
The standard-setting text in oncology for 40 years, DeVita, Hellman and Rosenberg""s Cancer: Principles and Practice of Oncology, 12th Edition, provides authoritative guidance and strategies for managing every type of cancer by stage and presentation. Drs. Vincent T. DeVita, Jr., Theodore S. Lawrence, and Steven A. Rosenberg oversee an outstanding team of expert contributing authors who keep you up to date and fully informed in this fast-changing field. This award-winning reference is also continually updated on Health Library and VitalSource platforms for the life of the edition.
- Integrates basic science into individual cancer chapters for more efficient reference
- Features quarterly updates that include late-breaking developments in oncology such as new drugs and clinical trials, as well as new case studies and interactive algorithms
- Offers balanced, multidisciplinary advice from a surgeon, a medical oncologist, and a radiation oncologist - Provides updated content on immunotherapy and genetics throughout
- Includes important related topics such as cancer screening and prevention, palliative care, supportive oncology, and quality of life issues
Enrich Your eBook Reading Experience:
- Read directly on your preferred device(s), such as computer, tablet, or smartphone.
- Easily convert to audiobook, powering your content with natural language text-to-speech.
CONTENTS:
PART I Etiology and Prevention of Cancer
1. Global Cancer Incidence and Mortality
2. Tobacco Use and the Cancer Patient
3. Lifestyle Factors
4. Genetic Counseling & Testing
PART II Cancer Therapeutics
5. Essentials of Radiation Therapy
6. Alkylating Agents
7. Platinum Analogs
8. Antimetabolites
9. Topoisomerase-Interacting Agents
10. Microtubule Inhibitors
11. Kinase Inhibitors as Anticancer Drugs
12. Histone Deacetylase Inhibitors, Demethylating Agents, and Epigenetic Drugs
13. Proteasome Inhibitors
14. Poly(ADP-Ribose) Polymerase Inhibitors for Tumors with Defects in DNA Repair
15. Miscellaneous Chemotherapeutic Agents
16. Hormonal Agents
17. Immunotherapy Agents: Monoclonal Antibodies
18. Immunotherapy Agents: Checkpoint Modulators
19. Immunotherapy Agents: Cellular Therapies
20. Immunotherapy Agents: Nonspecific Stimulators
21. Allogeneic Stem Cell Transplantation
PART III Practice of Oncology
22. Design and Analysis of Clinical Trials
SECTION 1. HEAD AND NECK
23. General Principles in the Management of Head and Neck Cancer
24. Cancer of the Nasopharynx
25. Cancer of the Larynx and Hypopharynx
26. Oropharynx Cancer
27. Cancer of the Oral Cavity
28. Cancer of the Nasal Vestibule, Nasal Cavity, and Paranasal Sinuses
29. Cancer of the Salivary Gland
SECTION 2. THORACIC CAVITY
30. Non-small-cell Lung Cancer
31. Small Cell and Neuroendocrine Tumors of the Lung
32. Neoplasms of the Mediastinum
SECTION 3. GI TRACT
33. Cancer of the Esophagus
34. Cancer of the Stomach
35. Cancer of the Pancreas
36. Cancer of the Liver
37. Cancer of the Biliary Tree
38. Small Bowel Cancer
39. Gastrointestinal Stromal Tumor
40. Cancer of the Colon
41. Cancer of the Rectum
42. Cancer of the Anal Region
SECTION 4. CANCERS OF THE GU TRACT
43. Cancer of the Kidney
44. Cancer of the Bladder, Ureter, and Renal Pelvis
45. Cancer of the Prostate
46. Cancer of the Urethra and Penis
47. Cancer of the Testis
SECTION 5. GYNECOLOGICAL CANCERS
48. Cancer of the Cervix
49. Cancer of the Vagina and Vulva
50. Cancer of the Uterine Body
51. Gestational Trophoblastic Neoplasia
52. Ovarian Cancer
SECTION 6. BREAST CANCER
53. Malignant Tumors of the Breast
SECTION 7. CANCER OF THE ENDOCRINE SYSTEM
54.Thyroid Tumors
55. Parathyroid Tumors
56. Adrenal Tumors
57. Pancreatic Neuroendocrine Neoplasms
58. Carcinoid Tumors and the Carcinoid Syndrome
59. Multiple Endocrine Neoplasia
SECTION 8. SARCOMAS AND SOFT TISSUE
60. Soft Tissue Sarcoma
61. Sarcomas of Bone
SECTION 9. CANCERS OF THE SKIN
62. Cancer of the Skin
63. Cutaneous Melanoma
SECTION 10. CNS
64. Neoplasms of the Central Nervous System
SECTION 11. CANCERS IN ADOLESCENTS AND YOUNG ADULTS
65. Adolescents and Young Adults with Cancer
SECTION 12. LYMPHOMAS IN ADULTS
66. Hodgkin Lymphoma
67. Non-Hodgkin Lymphoma
68. Cutaneous Lymphomas
69. Primary Central Nervous System Lymphoma
SECTION 13. LEUKEMIAS AND PLASMA CELL TUMORS
70. Management of Acute Leukemias
71. Chronic Myeloid Leukemia
72. Chronic Lymphocytic Leukemias
73. Myelodysplastic Syndromes
74. Plasma Cell Neoplasms
SECTION 14. OTHER CANCERS
75. Cancer of Unknown Primary
76. Benign and Malignant Mesothelioma
77. Peritoneal Metastases and Peritoneal Mesothelioma
78. Intraocular Melanoma
SECTION 15. ONCOLOGIC EMERGENCIES
79. Superior Vena Cava Syndrome
80. Increased Intracranial Pressure
81. Spinal Cord Compression
82. Metabolic Emergencies
SECTION 16. TREATMENT OF METASTATIC CANCER
83. Metastatic Cancer to the Brain
84. Metastatic Cancer to the Lungs
85. Metastatic Cancer to the Liver
86. Metastatic Cancer to the Bone
87. Malignant Pleural and Pericardial Effusions
88. Malignant Ascites
89. Paraneoplastic Syndromes
SECTION 17. MANAGEMENT OF ADVERSE EFFECTS OF TREATMENT
90. Neutropenia and Thrombocytopenia
91. Nausea and Vomiting
92. Diarrhea and Constipation
93. Oral Complications
94. Cardiac Toxicity
95. Gonadal Dysfunction
96. Fatigue
97. Neurocognitive Effects
98. Management of Cancer Pain
99. Nutrition Support
100. Sexual Problems
101. Psychiatric Distress and Resilience
102. How We Talk to Patients and How We Talk to Ourselves
103. Specialized Care of the Terminally Ill
PART IV Societal Issues
104. Cancer Survivorship
105. Minority Health and Cancer Health Disparities
106. Virtual Care and Telehealth in Oncology
107. Complementary, Alternative, and Integrative Therapies in Cancer Care
